Remix Therapeutics (Remix), Inc., a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced ...
Tracheobronchial adenoid cystic carcinoma (TACC) is a rare malignancy arising from the submucosal glands of the trachea or main bronchi. Similar to its more common salivary gland counterpart (SG-ACC), ...
SALT LAKE CITY, Feb. 8, 2021 /PRNewswire/ — Elevar Therapeutics, Inc. ("Elevar"), a fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results